Patents by Inventor FERNANDO A. ALVAREZ-NUNEZ

FERNANDO A. ALVAREZ-NUNEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MCL-1 INHIBITOR FORMULATIONS
    Publication number: 20230312606
    Abstract: Provided herein are solid dispersions comprising AMG 397, methods of preparing the solid dispersion, and pharmaceutical formulations comprising AMG 397.
    Type: Application
    Filed: August 24, 2021
    Publication date: October 5, 2023
    Applicant: AMGEN INC.
    Inventors: JAMES E. HUCKLE, MARKIAN M. STEC, TIAN WU, DARREN L. REID, FERNANDO A. ALVAREZ-NUNEZ, SEAN P. BROWN
  • PEDIATRIC FORMULATION
    Publication number: 20190216737
    Abstract: The present invention is directed to pediatric formulation of (R)—N-[-1-(1-naphthyl)-ethyl]-343-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride (hereinafter referred to as Cinacalcet HCl) and method of administering the same.
    Type: Application
    Filed: September 7, 2018
    Publication date: July 18, 2019
    Inventors: Mingda Bi, Fernando Alvarez-Nunez, Francisco Javier Alvarez
  • PEDIATRIC FORMULATION
    Publication number: 20180098940
    Abstract: The present invention is directed to pediatric formulation of (R)-N-[-1-(1-naphthyl)-ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride (hereinafter referred to as Cinacalcet HC1) and method of administering the same.
    Type: Application
    Filed: May 24, 2017
    Publication date: April 12, 2018
    Inventors: MINGDA BI, FERNANDO ALVAREZ-NUNEZ, FRANCISCO JAVIER ALVAREZ
  • IMMEDIATE RELEASE FORMULATIONS FOR OPROZOMIB
    Publication number: 20180078532
    Abstract: This disclosure features immediate release pharmaceutical formulations (e.g., solid dosage forms, e.g., tablets) that are useful for the oral administration of oprozomib, or a pharmaceutically acceptable salt thereof, to a human or animal subject as well as methods of making and using the formulations.
    Type: Application
    Filed: September 18, 2017
    Publication date: March 22, 2018
    Applicant: AMGEN INC.
    Inventors: John Inn CHUNG, Armen PIRJANIAN, Fernando ALVAREZ-NUNEZ, Jeffrey Michael KATZ, Dominick DAURIO
  • PEDIATRIC FORMULATION
    Publication number: 20140147497
    Abstract: The present invention is directed to pediatric formulation of (R)-N-[-1-(1-naphthyl)-ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride (hereinafter referred to as Cinacalcet HCl) and method of administering the same.
    Type: Application
    Filed: November 23, 2011
    Publication date: May 29, 2014
    Applicant: AMGEN INC.
    Inventors: Mingda Bi, Fernando Alvarez-Nunez, Francisco Javier Alvarez